{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:30:10Z","timestamp":1790562610923,"version":"4.1.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1210\/jc.2017-01542","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T18:06:29Z","timestamp":1506708389000},"page":"768-777","source":"Crossref","is-referenced-by-count":29,"title":["Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement"],"prefix":"10.1210","volume":"103","author":[{"given":"Kevin C J","family":"Yuen","sequence":"first","affiliation":[{"name":"Swedish Pituitary Center, Departments of Neuroendocrinology and Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders F","family":"Mattsson","sequence":"additional","affiliation":[{"name":"Pfizer Endocrine Care, Pfizer Health AB, Sollentuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Burman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5nes University Hospital, University of Lund, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Marie","family":"Erfurth","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5nes University Hospital, University of Lund, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Camacho-Hubner","sequence":"additional","affiliation":[{"name":"Pfizer Endocrine Care, Pfizer, Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L","family":"Fox","sequence":"additional","affiliation":[{"name":"Pfizer Endocrine Care, Pfizer, Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Verhelst","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, ZNA Middelheim Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell E","family":"Geffner","sequence":"additional","affiliation":[{"name":"Saban Research Institute, Children\u2019s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Abs","sequence":"additional","affiliation":[{"name":"Antwerp Centre for Endocrinology, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"issue":"4","key":"2019041117342869200_B1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"89","author":"Bunin","year":"1998","journal-title":"J Neurosurg"},{"issue":"7","key":"2019041117342869200_B2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1210\/jc.2011-0174","article-title":"Consequences of craniopharyngioma surgery in children","volume":"96","author":"M\u00fcller","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041117342869200_B3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3171\/2012.7.PEDS11436","article-title":"Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review","volume":"10","author":"Clark","year":"2012","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"2019041117342869200_B4","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"B\u00fclow","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041117342869200_B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9254","key":"2019041117342869200_B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"2019041117342869200_B7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2019041117342869200_B8","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/jc.2013-2000","article-title":"Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma","volume":"98","author":"Fjalldal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041117342869200_B9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2011-2817","article-title":"Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients","volume":"97","author":"Gautier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041117342869200_B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019041117342869200_B11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/jc.2013-3631","article-title":"Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma","volume":"99","author":"Yuen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041117342869200_B12","first-page":"574","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors","volume":"85","author":"B\u00fclow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041117342869200_B13","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041117342869200_B14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041117342869200_B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-16-0450","article-title":"Life expectancy in patients with pituitary adenoma receiving growth hormone replacement","volume":"176","author":"Olsson","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2019041117342869200_B16","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041117342869200_B17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117342869200_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients: 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"issue":"6","key":"2019041117342869200_B19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117342869200_B20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"2. Classification and diagnosis of diabetes","volume":"39","author":"American Diabetes Association","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"2019041117342869200_B21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/dc11-0449","article-title":"Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study","volume":"35","author":"Luger","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"2019041117342869200_B22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition: a consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"issue":"6","key":"2019041117342869200_B23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1530\/EJE-11-0599","article-title":"Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis","volume":"165","author":"Verhelst","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041117342869200_B24","first-page":"53","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm Res"},{"key":"2019041117342869200_B25","volume-title":"Statistical Models in Epidemiology","author":"Hughes","year":"1993"},{"key":"2019041117342869200_B26","volume-title":"Statistical Methods in Cancer Research. Vol. 2. The Design and Analysis of Cohort Studies.","author":"Breslow","year":"1987"},{"key":"2019041117342869200_B27","volume-title":"Cancer Incidence in Five Continents. Vol. 9. No. 160","author":"Curado","year":"2007"},{"issue":"2","key":"2019041117342869200_B28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diabres.2008.07.022","article-title":"Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden","volume":"82","author":"Thunander","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041117342869200_B29","unstructured":"World Health Organization . World health statistics 2008. Available at: http:\/\/www.who.int\/gho\/publications\/world_health_statistics\/EN_WHS08_Full.pdf. Accessed 31 October 2017."},{"issue":"4","key":"2019041117342869200_B30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.1.01877","article-title":"The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma","volume":"152","author":"Kendall-Taylor","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019041117342869200_B31","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database","volume":"87","author":"Attanasio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041117342869200_B32","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","article-title":"Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study","volume":"86","author":"Koranyi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041117342869200_B33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/EJE-12-0807","article-title":"Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis","volume":"168","author":"Abs","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019041117342869200_B34","doi-asserted-by":"crossref","first-page":"e0143084","DOI":"10.1371\/journal.pone.0143084","article-title":"Diabetes prevalence in Sweden at present and projections for year 2050","volume":"10","author":"Andersson","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"2019041117342869200_B35","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1210\/jc.2007-0458","article-title":"Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone","volume":"92","author":"Holmer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041117342869200_B36","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/en.2004-0225","article-title":"Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands","volume":"145","author":"Bogazzi","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"2019041117342869200_B37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041117342869200_B38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1530\/EJE-12-0077","article-title":"Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up","volume":"166","author":"Olsson","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2019041117342869200_B39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jc.2016-3402","article-title":"Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary\/sellar lesions","volume":"102","author":"Burman","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/2\/768\/23792173\/jc.2017-01542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T11:32:01Z","timestamp":1719487921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/2\/768\/4283045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,9,29]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01542","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,9,29]]}}}